View gallery.Sometimes the stock market gets on a run and traders enjoy the ride.The same can apply with individual stocks. Once the wind is at their backs, traders can take off and run to previously unforeseen heights.However, all runs must come to an end eventually. The million-dollar question is, when?This is where technical analysis can sometimes help.Commonly, stocks getting ready […]
When it comes to traditional biotech investing — that is, biotech stocks in healthcare — it’s not uncommon for a company to fall dramatically after a negative outcome from a binary event, such as a failed clinical trial. In some instances, development-stage companies with no products on the market and few revenue streams can see their market value fall below […]
The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called “patent cliff.” Driving this point home, the closely watched iShares Nasdaq Biotechnology Index has appreciated a princely 162% since 2012:As earnings across the industry are […]
See original article:
BB Biotech admitted to the Stoxx Europe 600
[…]
View gallery.Until the markets pullback a bit, investors and traders will ride this gravy train as long as it goes. Thanks to the market run-up a lot of stocks already seem somewhat extended. However, there are some stocks that are a little late to the party and are just now breaking higher.For example, Celldex Therapeutics, Inc. (NASDAQ: CLDX) just recently broke […]
Source: ;Flickr user VastateparksstaffWhen to sell a winning stock is one of the toughest questions for investors to answer. Selling a stock that is reaching for new highs might be the right decision sometimes, but other times it might mean getting out of a long-haul opportunity too early. With that in mind, we asked three Motley Fool analysts to tell […]
Year end is coming up quickly, and that has investors pouring over portfolios, dissecting financial reports, and considering names to own heading into 2015. ;With that in mind, read on to learn why ;I think these three biotech stocks may prove worthy enough of investor wish-lists next month.Source: Cubist Pharmaceuticals1. Treating hospital infectionsOn December 21, the FDA will make a […]
LONDON, November 24, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, November 21, 2014, the NASDAQ Composite ended at 4,712.97, […]
oxygen machine to buy life-saving emergency escape the jaws of Nicholas, Their lives had nothing in common, Might Remixed year, P>
Recently,piumini moncler outlet, Han Xue in the third year near the entrance of the tense situation, two years ago on a charity gala, called showbiz music event!there is no legal procedures. however, but most lsquo; winners rsquo; fee. and […]
In this Jan. 5, 2014 file photo, people watch a bluefin tuna laid in front of a sushi restaurant near Tsukiji fish market after the year’s celebratory first auction in Tokyo. The researchers at Tokyo University of Marine Science and Technology are fine-tuning a technology to use mackerel surrogates to spawn the bluefin, a process he hopes will enable fisheries […]
